Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS Currently down 0.19 (-0.48%) in today's trading session

Track congressional stock trades in Crinetics Pharmaceuticals, Inc. (CRNX). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Crinetics Pharmaceuticals, Inc. is currently trading at $39.44, positioned at 42% of its 52-week range ($25.83 – $57.99). View which politicians have recently bought or sold CRNX and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$39.44
24h Change
-0.19 (-0.48%)
52 Week Range
$25.83$57.99
View on NASDAQ

Crinetics Pharmaceuticals, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CRNX

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$4.13B

Volume

760.52K

Beta

0.31

P/E Ratio

-8.03

Fundamentals

EPS

$-4.91

Div. Yield

Open

$39.53

Day Range

$39.08 — $39.90

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
R. Scott Struthers
IPO Date
2018-07-18

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine...

Earnings

Next Report

Q1 2026

7 May

EPS Est.

$-1.20

Rev. Est.

$8.5M

Days Until

25

Recent Quarters

Q4 202526 Feb
EPS$-1.29
Beat 5.8%
Q3 20256 Nov
EPS$-1.38
Miss 8.7%
Q2 20257 Aug
EPS$-1.23
Miss 8.8%
Q1 20258 May
EPS$-1.04
Miss 5.0%
Q4 202427 Feb
EPS$-0.88
Beat 4.3%
Q3 202412 Nov
EPS$-0.96
Miss 5.4%
Q2 20248 Aug
EPS$-0.94
Miss 9.3%
Q1 20249 May
EPS$-0.93
Miss 10.7%
Q4 202328 Feb
EPS$-0.90
Miss 1.1%
Q3 20237 Nov
EPS$-1.01
Miss 13.5%
Q2 20238 Aug
EPS$-0.94
Miss 10.6%
Q1 20234 May
EPS$-0.85
Miss 3.7%
Q4 202228 Feb
EPS$-0.84
Miss 2.4%
Q3 202214 Nov
EPS$-0.78
Beat 0.0%
Q2 202212 Aug
EPS$-0.81
Miss 30.6%
Q1 202212 May
EPS$-0.73
Miss 30.4%
Q4 202130 Mar
EPS$-0.68
Miss 19.3%
Q3 20215 Nov
EPS$-0.73
Miss 4.3%
Q2 202110 Aug
EPS$-0.70
Miss 16.7%
Q1 20216 May
EPS$-0.69
Miss 6.2%
Q4 202030 Mar
EPS$-0.66
Miss 13.8%
Q3 20206 Nov
EPS$-0.56
Miss 7.7%
Q2 20207 Aug
EPS$-0.53
Miss 1.9%
Q1 20208 May
EPS$-0.71
Miss 12.7%
Q4 20199 Mar
EPS$-0.60
Beat 10.4%
Q3 201912 Nov
EPS$-0.60
Miss 11.1%
Q2 201913 Aug
EPS$-0.51
Miss 13.3%
Q1 201913 May
EPS$-0.37
Beat 5.1%
Q4 201813 Mar
EPS$-0.35
Beat 10.3%
Q3 201813 Nov
EPS$-0.38
Miss 11.8%
Q2 201830 Aug
EPS$-2.41
Miss 731.0%
Q2 201818 Jul
EPS$-0.25
Q3 201731 Dec
EPS$-0.18
Q2 201730 Sept
EPS$-0.17
Q1 201730 Jun
EPS$-0.12
Q4 201631 Mar
EPS$-0.19

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.